Table 5.
Analyses of the sensitivity of tumor markers in different stages of gallbladder cancer n (%)
| Clinical stages | Cases (n) | CEA | CA199 | CA242 | CA125 |
| II | 7 | 1 (14.2) | 3 (42.8)a | 4 (57.1)ac | 2 (28.5)a |
| IIIA | 10 | 1 (10) | 5 (50) | 6 (60) | 3 (30) |
| IIIB | 33 | 2 (6) | 18 (54.5) | 20 (60.6) | 14 (42.4) |
| IVA | 6 | 2 (33.3) | 4 (66.6) | 4 (66.6) | 3 (50) |
| IVB | 22 | 3 (13.6) | 16 (72.7) | 16 (72.7) | 13 (59) |
a
P < 0.05 vs sensitivity of stage IVA, B;
c
P < 0.05 vs sensitivity of CA125 and CA199. CA: Cancer antigen; CEA: Carcinoembryonic antigen.